Do I need treatment?
Some men need only observation. Others benefit from medicines. Surgery is mainly considered when symptoms remain significant or obstruction is causing clinical problems.
The useful question is not simply how large the prostate is. It is whether the prostate is causing troublesome symptoms, poor bladder emptying or complications—and which treatment offers the right balance for that individual patient.
Some men need only observation. Others benefit from medicines. Surgery is mainly considered when symptoms remain significant or obstruction is causing clinical problems.
A smaller prostate can obstruct badly, while a much larger prostate may cause relatively little difficulty. Symptoms, flow, residual urine and complications matter.
HoLEP, TURP and other procedures differ in technique, suitability, recovery profile and effects on ejaculation. The choice should be individualised.
Lower urinary tract symptoms can come from the prostate, the bladder, or both. The pattern and degree of bother matter more than simply ticking off a symptom list.
Reduced force, intermittency, straining or taking longer to empty.
Frequency, urgency and waking repeatedly at night to pass urine.
A persistent sensation that urine remains in the bladder after voiding.
Sudden or persistent inability to empty the bladder adequately.
Infection, bladder stones or bleeding may sometimes be linked to obstruction.
Long-standing obstruction may coexist with overactivity or reduced bladder contractility.
Not every urinary symptom in an older man is caused by the prostate. Assessment should connect the symptoms with objective findings and look for consequences of poor emptying.
There are situations where an operation becomes more important, but the final decision still depends on the complete clinical picture and patient priorities.
Symptoms remain significant despite an appropriate trial of conservative or medical treatment.
Recurrent or refractory retention, or continuing dependence on catheter drainage.
Repeated urinary infection where bladder outlet obstruction is an important contributing factor.
Stones associated with poor bladder emptying or chronic obstruction.
Obstruction associated with hydronephrosis or impaired kidney function requires particular attention.
Clinically important residual urine or recurrent bleeding attributed to benign prostate enlargement may influence the decision.
The indication for surgery comes first. Once surgery is appropriate, prostate anatomy, size, bleeding risk, bladder function, treatment goals and surgeon experience help determine the procedure.
Anatomical endoscopic enucleation. It can be used across a broad range of prostate sizes and removes tissue for pathology.
Endoscopic resection of obstructing prostate tissue. It remains an established operation, particularly for appropriately selected glands.
Vaporisation, aquablation, prostatic urethral lift, water-vapour therapy and other approaches may suit selected patients depending on anatomy and priorities.
This is a simplified comparison. Individual outcomes depend on anatomy, medical factors, equipment and surgeon experience.
| Feature | HoLEP | TURP |
|---|---|---|
| Basic principle | Anatomical enucleation of the obstructing adenoma | Resection of obstructing prostate tissue in chips |
| External incision | No | No |
| Prostate-size range | Can be used across a broad range of sizes | Commonly used for small-to-moderate glands; suitability varies with technique and setting |
| Tissue for pathology | Yes | Yes |
| Ejaculation | Frequently changes after surgery | Frequently changes after surgery |
| Selection depends on | Symptoms, anatomy, size, bladder function, medical factors, patient priorities and local expertise | |
Recovery varies. The early phase can include burning, urgency, frequency, intermittent blood in the urine and temporary changes in urinary control. Pre-operative bladder function and individual circumstances influence the pace of recovery.
No. Many men can be observed or treated with medicines. Surgery becomes more relevant when symptoms remain troublesome, simpler treatment is insufficient, or obstruction is causing complications.
No. HoLEP can be used across a broad range of prostate sizes when it is clinically appropriate. Large glands are an important use case, but size alone does not determine whether HoLEP should be performed.
No. Benign enlargement and cancer are different conditions. They can coexist, so cancer assessment is considered separately when indicated.
Changes in ejaculation are common after operations that open the prostate channel. This is worth discussing in detail before surgery, particularly if preservation of ejaculation is an important priority.
Patient information on this page is informed by contemporary urological guidance, including the European Association of Urology Guidelines on Non-neurogenic Male LUTS (2026) and the American Urological Association BPH Guideline. Guidelines support clinical decision-making but do not replace individual assessment.
If available, bring previous PSA reports, ultrasound, uroflowmetry, urine tests and your current medication list.